rhinosinus
rs
symptomat
diseas
classif
mani
caus
major
econom
burden
worldwid
wide
accept
rs
classifi
acut
ar
chronic
cr
rhinosinus
base
durat
symptom
viral
infect
play
larg
role
initi
potenti
diseas
review
examin
role
respiratori
viru
infect
exacerb
ar
cr
explor
epidemiolog
viral
exacerb
ar
cr
highlight
key
virus
may
caus
exacerb
also
review
current
understand
viral
infect
upper
airway
explain
put
underli
mechan
inflammatori
event
ar
cr
exacerb
advanc
accur
diagnosi
etiolog
respiratori
virus
ar
cr
symptom
lead
better
diseas
manag
also
survey
addit
current
treatment
provid
symptomat
relief
also
explor
potenti
har
exist
antivir
strategi
prevent
ar
cr
exacerb
especi
improv
viral
diagnost
tool
guid
accur
prescript
antivir
caus
respiratori
virus
rhinosinus
rs
condit
aris
inflamm
nose
paranas
sinus
result
two
symptom
includ
nasal
blockag
obstruct
congest
nasal
discharg
addit
symptom
may
includ
facial
pain
pressur
reduct
loss
smell
diagnosi
endoscop
sign
polyp
mucopurul
discharg
mucos
obstruct
middl
meatu
computer
tomographi
ct
chang
within
ostiomeat
complex
may
observ
rs
classifi
two
major
type
base
durat
natur
diseas
acut
rhinosinus
ar
involv
present
two
symptom
durat
less
week
damag
nasal
passag
often
revers
hand
chronic
rhinosinus
cr
involv
remodel
nasal
passag
due
longstand
inflamm
caus
persist
symptom
week
regardless
durat
ar
cr
caus
infect
pathogen
allergi
environment
allergen
howev
case
key
trigger
rs
often
viral
infect
either
initi
exacerb
symptom
rs
common
condit
encount
primari
care
account
popul
western
countri
preval
ar
rel
high
estim
preval
rate
worldwid
accord
variou
epidemiolog
studi
hand
studi
epidemiolog
preval
cr
less
comprehens
compar
ar
due
fact
cr
encompass
mani
form
present
confound
studi
paramet
account
preval
preval
preval
estim
usa
europ
base
compil
avail
studi
natur
diseas
rs
highli
depend
predispos
condit
allerg
rhiniti
nasal
deform
immun
defici
environment
factor
underli
condit
exacerb
follow
primari
damag
caus
viral
infect
secondari
damag
caus
host
respons
viru
result
patholog
rs
symptom
ar
primari
secondari
damag
result
perman
chang
nasal
passag
ar
symptom
aris
acut
infect
typic
subsid
within
week
hand
host
respons
trigger
viral
infect
caus
perman
alter
anatomi
nasal
passag
remodel
epitheli
layer
longterm
effect
may
present
form
cr
main
caus
ar
viral
host
immun
respons
lead
pathophysiolog
rs
mainli
antivir
natur
antivir
immun
respons
involv
nonspecif
specif
compon
requir
coordin
differ
cell
type
includ
neutrophil
macrophag
eosinophil
dendrit
cell
epitheli
cell
mast
cell
natur
killer
cell
lymphocyt
ideal
scenario
elicit
immun
respons
time
culmin
earli
viral
elimin
minim
damag
host
howev
cascad
inflamm
initi
epitheli
cell
normal
lead
damag
infiltr
cell
caus
edema
engorg
fluid
extravas
mucu
product
sinu
obstruct
process
eventu
lead
ar
exacerb
ar
exact
role
mechan
respiratori
virus
ar
exacerb
still
debat
often
specul
thelper
respons
initi
epitheli
innat
immun
respons
via
tolllik
receptor
tlr
due
viru
infect
depend
type
viral
pathogen
pathogensens
molecul
turn
activ
product
secret
nuclear
tumor
necrosi
potent
induc
recruit
neutrophil
macrophag
initi
action
neutrophil
virusinfect
cell
usual
contribut
earli
symptom
acut
respiratori
viru
infect
follow
secret
increas
recruit
cell
cytotox
tcell
lead
clearanc
viral
pathogen
viralinfect
cell
process
clear
viru
gener
dead
epitheli
infiltr
cell
contribut
patholog
ar
also
creat
environ
suitabl
secondari
bacteri
infect
staphylococcu
aureu
streptococcu
pneumonia
repres
anoth
factor
exacerb
ar
symptom
initi
viral
infect
hand
cr
patholog
straightforward
ar
former
associ
multipl
factor
diseas
present
howev
viru
infect
known
contribut
exacerb
cr
peopl
suffer
cr
often
predispos
factor
contribut
inflammatori
condit
nasal
passag
one
factor
remodel
nasal
epithelium
due
extend
period
inflamm
viral
infect
similar
inflammatori
process
caus
exacerb
ar
addit
destruct
epitheli
layer
macrophag
recruit
also
induc
product
matrix
key
remodel
protein
mediat
repair
epitheli
extracellular
matrix
remodel
nasal
passag
turn
exacerb
symptom
cr
even
normal
epitheli
function
diminish
due
possibl
hyperplasia
replac
epitheli
cell
fibroblast
follow
respiratori
viral
infect
virus
account
least
ar
occurr
rhinoviru
rv
respiratori
syncyti
viru
rsv
influenza
viru
coronaviru
corv
parainfluenza
viru
piv
adenoviru
adev
enteroviru
ev
play
major
role
ar
exacerb
virus
induc
strong
respons
lead
patholog
ar
exacerb
addit
rv
piv
may
contribut
exacerb
infect
upregul
viral
receptor
major
type
rv
tan
et
al
unpublish
observ
also
signal
protein
activ
migrat
infiltr
immun
cell
contribut
exacerb
pathophysiolog
ar
rv
corvar
common
virus
isol
adult
ar
account
approxim
ar
diagnosi
geograph
also
virus
isol
patient
ar
eg
human
bocaviru
frequent
isol
ar
case
taiwan
hand
virus
exacerb
ar
also
caus
similar
exacerb
cr
patient
high
rate
viral
detect
nasal
wash
cr
patient
includ
virus
commonli
found
ar
patient
rv
also
preval
viru
cr
exacerb
human
bocaviru
metapneumoviru
hmpv
also
found
nasal
wash
cr
patient
flare
up
moreov
also
certain
virus
herp
viru
epsteinbarr
viru
human
cytomegaloviru
found
cr
patient
nasal
polyp
current
unclear
whether
contribut
exacerb
cr
due
multifactori
natur
cr
exacerb
rel
harder
identifi
key
virus
exacerb
cr
compar
ar
thu
direct
associ
cr
viral
exacerb
still
unclear
put
underli
mechan
viral
ar
cr
exacerb
summar
fig
caus
rs
especi
ar
almost
exclus
viral
natur
diagnosi
specif
viral
infect
import
prevent
unnecessari
prescript
antibiot
clinic
practic
viral
infect
usual
diagnos
symptomat
assess
lack
object
diagnost
tool
confirm
well
identif
type
viral
infect
howev
develop
rapid
viral
assay
diagnost
kit
viral
detect
identif
perform
within
pointofcar
set
sensit
specif
identif
respiratori
viru
infect
patient
present
ar
cr
exacerb
current
viral
detect
system
featur
use
clinic
set
summar
tabl
current
assay
rapid
detect
respiratori
virus
includ
viru
detect
antigen
detect
molecular
detect
rapid
viru
detect
cultur
shell
vial
cluster
tray
facilit
detect
adenoviru
influenza
b
viru
piv
hmpv
rsv
within
h
assay
viru
antigen
detect
involv
use
viral
antigenspecif
antibodi
use
direct
fluoresc
antibodi
test
rapid
antigen
test
direct
fluoresc
antibodi
test
detect
adev
influenza
b
viru
hmpv
piv
rsv
within
min
rapid
direct
antigen
test
util
immunochromatograph
antibodi
detect
kit
simpl
perform
detect
min
far
limit
detect
influenza
b
viru
rsv
lastli
molecular
detect
includ
amplif
viral
nucleic
acid
sequenc
polymeras
chain
reaction
patient
sampl
assay
detect
respiratori
virus
high
sensit
specif
within
short
time
frame
min
recogn
play
import
role
respiratori
viral
diagnosi
due
versatil
addit
method
also
serolog
detect
elisa
detect
antibodi
viru
howev
serolog
detect
wide
use
current
diagnost
set
suitabl
diagnost
acut
infect
caus
ar
cr
exacerb
therefor
discuss
review
current
rapid
cultur
direct
fluoresc
antibodi
molecular
detect
necessit
special
laboratori
attach
larger
hospit
perform
diagnosi
identif
virus
caus
ar
cr
exacerb
due
complex
train
oper
assay
pointofcar
detect
method
rapid
direct
antigen
test
immunochromatographi
test
suffer
sensit
issu
may
lead
fals
neg
misdiagnosi
therefor
imper
continu
improv
diagnost
kit
rapidli
accur
pinpoint
caus
agent
ar
cr
exacerb
prevent
inappropri
prescript
treatment
exacerb
episod
especi
misus
antibiot
viralinduc
exacerb
ar
cr
clinic
manag
ar
cr
exacerb
due
viru
infect
similar
episod
ar
cr
exacerb
treatment
usual
aim
resolv
reliev
symptom
infect
resolv
symptomat
treatment
involv
use
nasal
decongest
topic
corticosteroid
reliev
nasal
congest
reduc
nasal
edema
nonsteroid
antiinflammatori
drug
nsaid
may
also
use
decreas
inflamm
aris
viral
infect
reliev
symptom
fever
nasal
edema
secondari
bacteri
infect
suspect
narrowspectrum
antibiot
amoxicillin
prescrib
addit
symptomat
manag
relief
treatment
prevent
ar
cr
exacerb
enhanc
advanc
viral
detect
identifi
exact
viral
etiolog
use
antivir
treatment
viral
load
nasal
epithelium
reduc
therefor
lower
inflamm
associ
infect
reduc
rs
symptom
durat
henc
possibl
add
current
avail
antivir
repertoir
prevent
therapeut
strategi
counter
viral
exacerb
episod
ar
cr
perspect
exploit
antivir
agent
prevent
treat
ar
cr
exacerb
influenza
viru
infect
widest
array
therapi
adamantan
deriv
amantadin
rimantadin
block
influenza
fusion
current
recommend
treatment
due
widespread
resist
still
multipl
neuraminidas
inhibitor
specif
influenza
virus
avail
therapeut
agent
sever
episod
ar
cr
exacerb
exampl
oseltamivir
laninamivir
peramivir
zanamivir
specif
inhibit
replic
influenza
virus
thu
prevent
minim
effect
ar
cr
exacerb
treatment
may
har
use
prophylaxi
influenza
season
patient
sever
episod
ar
cr
exacerb
addit
neuraminidas
inhibitor
annual
influenza
vaccin
also
serv
mean
prevent
ar
cr
exacerb
due
influenza
viru
infect
hand
common
respiratori
infect
due
rv
piv
rsv
corv
adev
suitabl
vaccin
limit
antivir
agent
use
palivizumab
monoclon
antibodi
target
fusion
rsv
use
prophylaxi
infant
high
risk
morbid
mortal
rsv
complic
also
broadspectrum
antivir
ribavirin
prevent
viral
rna
synthesi
use
influenza
viru
rsv
piv
certain
extent
coronaviru
reserv
sever
case
due
undesir
advers
effect
similarli
cidofovir
dna
synthesi
inhibitor
use
dissemin
adenoviru
infect
last
line
defens
sever
adenoviru
diseas
due
concern
toxic
date
noninfluenza
antivir
respiratori
virus
still
earli
stage
develop
may
yet
optim
prevent
manag
viral
ar
cr
exacerb
notwithstand
also
investig
agent
clinic
trial
phase
close
avail
clinic
treatment
may
use
near
futur
treat
respiratori
viral
infect
manag
viral
ar
cr
exacerb
favipiravir
far
test
efficaci
influenza
viru
evalu
rna
virus
recent
approv
market
japan
sever
influenza
fludas
fusion
protein
prevent
influenza
infect
current
phase
ii
clinic
trial
presatovir
inhibitor
rsv
replic
undergo
trial
potenti
treatment
rsv
found
efficaci
minim
side
effect
investig
agent
exploit
futur
effect
measur
manag
viral
exacerb
ar
cr
detail
inform
current
antivir
drug
respiratori
virus
mechan
action
discuss
fig
tabl
ar
cr
remain
consider
econom
public
health
burden
worldwid
due
high
preval
viru
infect
establish
key
caus
case
rs
exacerb
especi
ar
attent
focus
proper
studi
diagnosi
prevent
manag
treatment
viralinduc
exacerb
ar
cr
symptom
detail
perspect
virolog
ar
cr
exacerb
enhanc
current
understand
rs
improv
qualiti
treatment
episod
ar
cr
exacerb
well
